$2.58: The Egg Industry’s Rapid Shift From Crisis to Collapse
$2.58. That’s the current national average price for a dozen eggs, a figure that encapsulates a stunning reversal of fortune for both American consumers and the farmers who supply them. While shoppers celebrate a 34% year-over-year price decrease – a welcome reprieve from last year’s record highs – the egg industry is bracing for potential contraction, a direct consequence of oversupply and a cost-of-production squeeze. Follow the money, and a clear picture emerges: a market swinging violently between scarcity-driven profits and loss-inducing abundance.
The story begins with the avian flu. Last winter’s outbreak decimated flocks, wiping out an estimated 70 million egg-laying birds, according to Emily Metz, president and CEO of the American Egg Board. This triggered a supply shock, sending prices soaring and prompting widespread consumer anxiety. Demand remained consistent, but the available supply simply couldn’t meet it. Farmers, incentivized by high prices, aggressively rebuilt their flocks as outbreaks subsided. This rapid restocking, aided by biosecurity measures and a $100 million USDA investment in avian flu vaccine research, proved too effective.
Now, the pendulum has swung in the opposite direction. Wholesale egg prices currently trade at 92 cents nationally – the lowest level in three years, as reported by the USDA. This is critically below the production cost for many farmers, which ranges from 98 cents to $1.05 per dozen, according to Jada Thompson, an associate professor of agricultural economics at the University of Arkansas. These figures don’t even account for rising operational costs like packaging and transportation, further eroding profit margins. Mike Puglisi, owner of Puglisi Egg Farms, which produces 486 million eggs annually, succinctly describes the situation: “We appear to be making more eggs than are needed.”
Based on the original CNN report.
The impact isn’t uniform. Farmers who lost significant portions of their flocks to the avian flu in 2022 are facing a particularly precarious situation. Rebuilding after a complete loss, only to be met with depressed prices upon re-entry into the market, represents a devastating financial blow. Puglisi himself, having weathered a total flock loss in 2022, anticipates widespread hardship. “They could be in a precarious position at this point,” he warns, highlighting the risk of bankruptcies among smaller producers. The American Egg Board echoes this concern, stating that prolonged low prices will inevitably lead to farm closures and a reduction in industry competition.
This potential consolidation presents a long-term risk. Fewer farms mean reduced supply capacity, setting the stage for future shortages and price spikes. Thompson explains the cyclical nature of the problem: “That company goes out of business, you have less competition. So now we might have shortages of eggs later on.” The industry is also grappling with shifting consumer behavior. Last year’s high prices prompted some Americans to reduce their egg consumption, and regaining that demand will take time, according to Michael Swanson, chief agricultural economist at Wells Fargo’s Agri-Food Institute. He notes that “It will take low prices to get consumers to increase their demand, and that will take time.”
The industry’s proposed solution – a vaccine against avian flu – is fraught with complications. While a vaccine could mitigate future outbreaks, it doesn’t prevent the spread of the virus, and crucially, many international markets reject poultry from vaccinated birds, jeopardizing export opportunities. Metz argues that a vaccine is still a necessary tool, stating it “will bring a level of certainty and calm to the egg industry that’s desperately needed.” However, the trade-offs remain significant.
What this means for your wallet: expect continued low egg prices in the short term, but be prepared for potential price increases down the line if farm closures reduce supply. More importantly, watch for the USDA’s progress on avian flu vaccine development and the international response. Will the benefits of a vaccine outweigh the risks to export markets? The answer will determine whether the egg industry can break free from this cycle of boom and bust.
